Back to GetFilings.com




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549

FORM 10-Q


X   QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

   For the quarterly period ended    March 31, 2004        
 
Commission file number       1-71        

 
 
 
New Jersey
 
13-0511250


(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)

180 East Broad Street, Columbus, Ohio 43215

(Address of principal executive offices)
 
(614) 225-4000

(Registrant’s telephone number, including area code)
 
Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.
Yes __ No _X_

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes No _X_

Number of shares of common stock, $0.01 par value, outstanding as of the close of business on May 11, 2004: 200,895,628
 
     

 

BORDEN CHEMICAL, INC.

INDEX


<TABLE><CAPTION>
<BTB>
 
<S>
 
PART I – FINANCIAL INFORMATION
 
 
 
Item 1. Borden Chemical, Inc. Consolidated Financial Statements
 
 
 
Consolidated Statements of Operations and Comprehensive Income, three months ended March 31, 2004......................................................................................    
3
Consolidated Balance Sheets, March 31, 2004 and December 31, 2003......................................................................................................................................................    
4
Consolidated Statements of Cash Flows, three months ended March 31, 2004 and 2003.......................................................................................................................    
6
Consolidated Statement of Shareholders’ Deficit, three months ended March 31, 2004.........................................................................................................................    
7
Notes to Consolidated Financial Statements..................................................................................................................................................................................................    
8
 
 
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations    
20
 
 
Item 3. Quantitative and Qualitative Disclosures about Market Risk…..…...…………………………
26
 
 
Item 4. Controls and Procedures ………...……..…………………………………………………………
26
 
 
 
 
PART II – OTHER INFORMATION
 
 
 
Item 1. Legal Proceedings……………………………………………………………………………………….
27
 
 
Item 2. Change in Securities and Use of Proceeds………………………………………………………………
27
 
 
Item 3. Defaults upon Senior Securities…………………………………………………………………………
27
 
 
Item 4. Submission of Matters to a Vote of Security Holders…………………………………………………..
27
 
 
Item 6. Exhibits and Reports on Form 8-K …………………………….………………………………………
27
 
 
</TABLE>


     



PART 1
 
 
 
 
Item 1. Borden Chemical, Inc. Consolidated Financial Statements
 
 
 
 
 
 
 




CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE INCOME (UNAUDITED)
BORDEN CHEMICAL, INC.
 
 
 
 
Three Months ended March 31, 
(In thousands, except per share data)
2004
 
2003




 
 
 
 
Net sales
$385,434
 
$349,288
Cost of goods sold
309,537
 
283,454


 
 
 
 
Gross margin
75,897
 
65,834


 
 
 
 
Distribution expense
17,505
 
16,734
Marketing expense
11,403
 
10,273
General & administrative expense
23,409
 
29,691
Business realignment expense and impairments
1,494
 
1,296
Other operating expense
1,284
 
635


 
 
 
 
Operating income
20,802
 
7,205


 
 
 
 
Interest expense
11,841
 
11,340
Affiliated interest expense
49
 
194
Other non-operating expense
        61
 
     467
 
 
 
 
Income (loss) before income tax
8,851
 
(4,796)
Income tax expense (benefit)
3,937
 
(1,391)


 
 
 
 
Net income (loss)
$ 4,914
 
$ (3,405)


 
 
 
 
Comprehensive income
$ 5,638
 
$ 4,669


 
 
 
 
Basic and Diluted Per Share Data
 
 
 

 
 
 
 
Net income (loss) - basic and diluted
$ 0.02
 
$ (0.02)


Average number of common shares outstanding during the period – basic
200,896
 
200,903
 
 
 
 
Average number of commn shares outstanding during the period – diluted
200,949
 
200,903
 
 
 
 




See Notes to Consolidated Financial Statements
 
 
 






 
     

 

CONSOLIDATED BALANCE SHEETS
 
 
 
BORDEN CHEMICAL, INC.
 
 
 
 
 
 
 
(In thousands)
 
 
 
 
(Unaudited)
March 31,
 
December 31,
ASSETS
2004
 
2003




 
 
 
 
Current Assets
 
 
 
Cash and equivalents
$ 29,632
 
$ 28,162
Accounts receivable (less allowance for doubtful accounts of $13,395 in 2004 and $14,459 in 2003)
200,633
 
196,093
Accounts receivable from affiliates
 181
 
354
Inventories:
 
 
 
     Finished and in-process goods
36,758
 
42,292
     Raw materials and supplies
42,285
 
38,819
Deferred income taxes
23,717
 
27,085
Other current assets
  12,848
 
13,551


 
346,054
 
346,356


 
 
 
 
Investments and Other Assets
 
 
 
Deferred income taxes
 118,278
 
113,434
Other assets
22,640
 
21,725


 
140,918
 
135,159


 
 
 
 
Property and Equipment
 
 
 
Land
 32,824
 
32,585
Buildings
 104,461
 
103,774
Machinery and equipment
 698,673
 
691,249


 
 835,958
 
827,608
Less accumulated depreciation
(389,909)
 
(378,724)


 
446,049
 
448,884
 
 
 
 
 
 
 
 
Goodwill
 57,753
 
57,516
Other Intangible Assets
 5,525
 
5,951


 
 
 
 
Total Assets
$996,299
 
$993,866


 
 
 
 




See Notes to Consolidated Financial Statements
 
 
 




 
     

 

CONSOLIDATED BALANCE SHEETS
 
 
 
BORDEN CHEMICAL, INC.
 
 
 
 
 
 
 
(In thousands except share data)
 
 
 
 
(Unaudited)
March 31,
 
December 31,
LIABILITIES AND SHAREHOLDERS’ DEFICIT
2004
 
2003




 
 
 
 
Current Liabilities
 
 
 
Accounts and drafts payable
$ 143,376
 
$ 127,174
Accounts payable to affiliates
 
16
Debt payable within one year
5,484
 
8,167
Loans payable to affiliates
13,300
 
18,260
Other current liabilities
  82,219
 
103,231


 
244,381
 
256,848


 
 
 
 
Other Liabilities
 
 
 
Long-term debt
 532,651
 
529,966
Non-pension post-employment benefit obligations
125,334
 
128,723
Other long-term liabilities
184,190
 
174,522


 
842,175
 
833,211


 
 
 
 
Commitments and Contingencies (See Note 8)
 
 
 
 
 
 
 
Shareholders’ Deficit
 
 
 
Common stock - $0.01 par value: authorized 300,000,000 shares,
 
 
 
Issued 201,754,598, treasury 858,970, outstanding 200,895,628 shares in 2004 and 2003
2,009
 
2,009
Paid-in capital
1,236,155
 
1,224,011
Receivable from parent
(524,238)
 
(512,094)
Deferred compensation
(1,190)
 
(1,488)
Accumulated other comprehensive income
(127,469)
 
(128,193)
Accumulated deficit
(675,524)
 
(680,438)


 
(90,257)
 
(96,193)


 
 
 
 
Total Liabilities and Shareholders’ Deficit
$996,299
 
$993,866


 
 
 
 




See Notes to Consolidated Financial Statements
 
 
 





 
     

 

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
 
 
 
BORDEN CHEMICAL, INC.
 
 
 
 
Three months ended March 31,
(In thousands)
2004
 
2003




 
 
 
 
Cash Flows from (used in) Operating Activities
 
 
 
Net income (loss)
$ 4,914
 
$ (3,405)
Adjustments to reconcile net income (loss) to net cash from (used in) operating activities: